Research Article
Synthesis and Microbial Activity of Novel 3-Methyl-2-pyrazolin-5-one Derivatives
Table 4
Antimicrobial activity of prepared compounds.
| Compd. no. | Inhibition zones (mm) | Gram +ve bacteria | Gram −ve bacteria | Fungi | B. subtilis | S. aureus | E. coli | C. albicans |
| 2a | 18 | 14 | 12 | 19 | 2b | 13 | 10 | 11 | 20 | 3b | 16 | 14 | 10 | 13 | 3c | 14 | 12 | 15 | 11 | 4b | 17 | 18 | 18 | 22 | 4c | 22 | 17 | 16 | 20 | 5a | 29 | 10 | 21 | 19 | 5b | 23 | 10 | 11 | 18 | 5c | 19 | 15 | 20 | 10 | 5d | 23 | 10 | 19 | 25 | 5e | 22 | 14 | 13 | 15 | 5f | 20 | 18 | 22 | 13 | Tetracycline | 28 | 26 | 20 | — | Nystatin | — | — | — | 24 |
|
|